Effects and Mechanism of Two Hybrid Exercise-cognitive Trainings in Mild Ischemic Stroke With Cognitive Decline

Stroke Patients With Cognitive Decline Clinical Trial

Official title:

Effects and Mechanism of Two Hybrid Exercise-cognitive Trainings in Mild Ischemic Stroke With Cognitive Decline: fMRI for Brain Plasticity, and Biomarker and Behavioral Analysis

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03230253
• Other study ID #: KMUHIRB-F(II)-20170040
• Status: Completed
• Phase: N/A
• Start date: April 19, 2018
• Est. completion date: July 31, 2020

Study information

• Verified date: September 2020
• Source: Chang Gung Memorial Hospital
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The purposes are to: (1) examine and compare the effects of two hybrid interventions on brain plasticity, physiological biomarkers and behavioral outcomes, including cognitive and physical functions, from pre- to post-training; (2) understand the neural mechanisms of cognitive recovery following two hybrid interventions using the functional magnetic resonance imaging (fMRI); (3) examine the long-term benefits of the two hybrid therapies; (4) to identify the correlations between brain activity, biomarkers and behavioral measures.

Description:

Cognitive decline after stroke is highly associated with functional disability. Empirical evidence shows that exercise combined cognitive training may induce neuroplastic changes that modulate cognitive function. However, it is unclear whether hybridized exercise-cognitive trainings can facilitate cortical activity and physiological outcome measures and further influence on the cognitive function after stroke. We aim to investigate the effects of two hybridized exercise-cognitive trainings on brain plasticity, physiological biomarkers and behavioral outcomes in stroke survivors with cognitive decline. This study is a single-blind randomized controlled trial. A target sample size of 75 participants will be recruited. Stroke survivors with mild cognitive decline will be stratified by Mini-Mental State Examination scores and then randomized 1:1:1 to sequential exercise-cognitive training, dual-task exercise-cognitive training or control groups. All groups will undergo trainings 60 min/day, 3 days/week, for a total of 12 weeks. The primary outcome is the resting-state functional connectivity and neural activation in the frontal, parietal and occipital lobes in functional magnetic resonance imaging. Secondary outcomes include physiological biomarkers, cognitive functions, physical function, daily functions and quality of life.

This study may differentiate the effects of two hybridized trainings on cognitive function and health-related conditions and detect appropriate neurological and physiological indices to predict training effects. This study capitalizes on the groundwork for non-pharmacological intervention of cognitive decline after stroke.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 44
• Est. completion date: July 31, 2020
• Est. primary completion date: July 3, 2020
• Accepts healthy volunteers: No
• Gender: All
• Age group: 20 Years to 80 Years

Eligibility

Inclusion Criteria:

1. Stroke occurring at least 6 months prior to enrollment

2. Age range from 20 to 80 years

3. MMSE score < 28 or MoCA<25

4. Able to follow the study instruction

5. Adequate cardiopulmonary function to perform aerobic exercise

6. Able to walk with or without assistive devices

Exclusion Criteria:

1. Unstable medical history (e.g., recent myocardial infarction) that might limit participation

2. Concomitant with other neurological disorders (e.g., Parkinson's disease, amyotrophic lateral sclerosis, multiple sclerosis)

3. Current participation in another interventional trial

4. Any contraindication to MRI (metallic implants, claustrophobia, seizure, pacemakers, et al)

5. Pregnant woman

Related Conditions & MeSH terms

• Cognitive Dysfunction
• Stroke
• Stroke Patients With Cognitive Decline

Intervention

Behavioral:
• Sequential training
The participant will cycle on a stationary bike for 30 minutes, which includes a 3-min warm-up phase followed by the aerobic training components (25 minutes), then a 2-min cool-down phase. The target heart rate during the aerobic training phase will be 40 to 70% of maximal heart rate (HRmax). After cycling, the participant will engage in a 30-minute of computer-based cognitive training program using BrainHQ (Posit Science Inc., San Francisco, CA, USA). The following are the areas of training: visuospatial processing, attention, memory, language, and logical thinking.
• Dual training
The dual-task training group will cycling concurrently with the computer-based cognitive training. The training principle of cycling and cognitive training is similar to the SEQ group; however, the training intensity will be adjusted according to each participant's ability.
• Control training
The control participants will receive 60 minutes of health-related rehabilitation programs which involves non-aerobic physical exercise (e.g., muscle stretching, range of motion exercises, relaxation techniques) and unstructured cognitive related rehabilitation programs (e.g., watch health-related videos or read newspapers or magazines and then answer the content-related questions raised by the therapist).

Locations

Country	Name	City	State
Taiwan	Kaohsiung Municipal Siaogang Hospital	Kaohsiung

Sponsors (1)

Lead Sponsor	Collaborator
Chang Gung Memorial Hospital

Country where clinical trial is conducted

Taiwan, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	fMRI (change is being assessed)	Resting-state functional connectivity and neural activation in the frontal, parietal and occipital lobes	Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months).
Secondary	Serum BDNF level	Up-regulation of neurotrophic and vascular growth factors	Baseline, posttest (an expected average of 3 months)
Secondary	Antioxidative marker	Antioxidative markers will be used to reflect the changes on oxidative stress. In particular, we will be analyzing the total antioxidant capacity (TAC).	Baseline, posttest (an expected average of 3 months)]
Secondary	Glucose indicator	HbA1C level will be tested to investigate the relationships between blood glucose level and aerobic exercise	Baseline, posttest (an expected average of 3 months)
Secondary	Plasma lipid level	The cholesterol ratio (total cholesterol divided by high-density lipid) will be evaluated to reflect the lipid level in the blood	Baseline, posttest (an expected average of 3 months)
Secondary	Montreal Cognitive Assessment (MoCA)	The MoCA will be used to assess general cognitive functions. It examines several cognitive domains with a total score of 30	Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
Secondary	Wechsler Memory Scale - Third Edition (WMS-III)	The WMS-III is a standardized and reliable neuropsychological examination tool designed to evaluate visuospatial and memory functions	Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
Secondary	Wechsler Adult Intelligence Scale - Third Edition (WAIS-III)	The WAIS-III is developed to measure an individual's intelligence level. It includes tests that evaluate cognitive functions in verbal comprehension, working memory, perceptual organization, and processing speed	Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
Secondary	Useful Field of View (UFOV)	The UFOV assessment is a computer-based visual test containing three subtests: visuomotor processing speed, divided attention, and selective attention.	Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
Secondary	Stroop Color-Word test	The Stroop Color-Word assesses the abilities of selective attention, inhibition and executive function. The participants will be tested under congruent and incongruent conditions.	Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
Secondary	Dual-task test	The dual-task test evaluates the ability to shift attention between one task and another. Participants will perform the box and block test (BBT) while doing secondary cognitive tasks while sitting. Participants will perform BBT by affected and less affected hand.	Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
Secondary	Time up and go test (TUG)	The TUG assesses the dynamic balance ability and mobility. The participants will be required to stand up from a chair, walk 3 meters, turn around, walk back to the chair, and sit down.	Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
Secondary	Six-minute walk test (6MWT)	The 6MWT measures the maximum distance walked over 6 minutes, which assess the endurance and mobility level of the participants. The participants could rest as needed during the course of the test.	Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
Secondary	International Physical Activity Questionnaires (IPAQ)	The IPAQ is an international measure of health-related physical activity.	Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
Secondary	Fugl-Meyer Assessment (FMA)	The 33-item upper limb subscale of the FMA will be used to assess motor impairments.	Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
Secondary	Rivermead Mobility Index (RMI)	The RMI evaluates the participant's bed mobility, postural transfers and walking ability. It contains a 15-item scale which includes 14 questions and one direct observation, with a total of score of 15.	Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
Secondary	Muscle strength	Accelerometers will be used to provide an objective measure of the amount of arm movements in real-life situations. The participants will be asked to wear an Actigraphy activity monitor.	Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
Secondary	Mobility level	Accelerometers will be used to provide an objective measure of the amount of arm movements in real-life situations. The participants will be asked to wear an Actigraphy activity monitor.	Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
Secondary	Functional Independence Measure (FIM)	The FIM assesses the dependence level of individuals with stroke to perform 18 activities (13 motor and five cognitive tasks) in daily living. The score ranges from 18 to 126 and higher scores demonstrate greater independent participation in daily activities.	Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
Secondary	Lawton Instrumental Activities of Daily Living Scale (Lawton LADL)	The Lawton IADL scale assesses independent living skills, such as shopping or managing finances.	Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
Secondary	Stroke Impact Scale (SIS)	The SIS 3.0 will be used to evaluate health-related quality of life for patients with stroke. The SIS assesses eight domains (strength, hand function, ADL/IADL, mobility, communication, emotion, memory and thinking, and participation/role function) with 59 test items.	Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
Secondary	Caregiver Burden Scale (CB scale)	B scale evaluates the burden of the primary caregiver of the participants. Lessening the burden of caregivers after the intervention may significantly improve the quality of life for patients with stroke and their family.	Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
Secondary	EuroQol-5D questionnaire (EQ-5D)	The quality of life will be assessed by the EQ-5D questionnaire which comprises the following five dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression.	Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)